Type 2 DM An Independent Risk Factor For Poor Outcome In Moderate To Severe COVID-19

Simple item page
dc.contributor.authorMitra, Sen_US
dc.contributor.authorMuley, Aen_US
dc.contributor.authorBavishi, Aen_US
dc.contributor.authorBhojani, Hen_US
dc.contributor.authorNakum, Den_US
dc.contributor.authorParikh, Ven_US
dc.contributor.authorMore, Sen_US
dc.contributor.authorMehta, V.en_US
dc.date.accessioned2023-07-14T08:27:06Z
dc.date.available2023-07-14T08:27:06Z
dc.date.issued2022-05
dc.description.abstractBackground:Diabetes Mellitus has been shown to be a risk factor for severe COVID-19 disease. Few studies asse ssed effect of diabetes on the outcome exclusively in moderate to severe COVID 19 disease. Objective: To compare the clinical characteristics and outcome of hospitalized moderate and severe COVID-19 disease among patients with and without diabetes. Material And Methods:This retrospective study was conducted at Parul Sevashram Hospital from 1stApril 2021-30thApril 2021. Data on demographic profile, clinical symptoms, laboratory findings, complications and clinical outcome was collected and compared between patients with and without diabetes.Result:Total 319 patients were included with mean age 54.81±11.72 years. 28.5% had diabetes. The most common symptoms were fever, cough and shortness of breath. As compared to patients without diabetes, these patients had significantly higher levels of leucocyte count, CRP, Ferritin, LDH and D-Dimer. They also had more complications like ARDS, secondary infection and stroke and higher need of respiratory support (92.3% vs. 69.7%, P < 0.001). We also observed significantly greater mortality in patients with diabetes compared to those without diabetes (29.7% vs. 13.6%; P = 0.0014). These findings held true even on comparingpatients with only diabetes as comorbidity to those without any comorbidity.Conclusion:The study confirms that diabetes is an independent risk factor for higher inflammatory markers, risk of complications and in hospital mortality during hospitalization with moderate to severe COVID 19. New strategies are needed for more aggressive management of COVID 19 cases with diabetes to improve prognosis in these cases.en_US
dc.identifier.affiliationsClinical Research Associateen_US
dc.identifier.affiliationsProfessoren_US
dc.identifier.affiliationsInfectious Disease Specialisten_US
dc.identifier.affiliationsAssistant Professoren_US
dc.identifier.affiliationsSenior Residenten_US
dc.identifier.affiliationsIntern, Department Of Medicineen_US
dc.identifier.affiliationsMPH Scholar, PIMSR, Parul University, Waghodia, Vadodara, Gujarat, Indiaen_US
dc.identifier.citationMitra S, Muley A, Bavishi A, Bhojani H, Nakum D, Parikh V, More S, Mehta V.. Type 2 DM An Independent Risk Factor For Poor Outcome In Moderate To Severe COVID-19 . National Journal of Integrated Research in Medicine. 2022 May; 13(2): 11-19en_US
dc.identifier.issn0975-9840
dc.identifier.issn2230 - 9969
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/219859
dc.languageenen_US
dc.publisherAssociation of Health Professionals and Health Educatorsen_US
dc.relation.issuenumber2en_US
dc.relation.volume13en_US
dc.source.urihttps://nicpd.ac.in/ojs-/index.php/njirm/article/view/3448en_US
dc.subjectCOVID-19en_US
dc.subjectDiabetes Mellitusen_US
dc.subjectSeverityen_US
dc.subjectMortalityen_US
dc.titleType 2 DM An Independent Risk Factor For Poor Outcome In Moderate To Severe COVID-19en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
NJIRM2022v13n2p11.pdf
Size:
964.51 KB
Format:
Adobe Portable Document Format
Download
Collections
National Journal of Integrated Research in Medicine